Medica Spa announced Thursday that it has received 510k clearance from the U.S. FDA, through its subsidiary Tecnoideal America Inc, to market hemoconcentrators, manufactured by Medica, in the U.S..
Medica Spa reported Tuesday that it closed 2023 with revenues of EUR80.0 million, up from EUR50.9 million in the previous year. The revenue growth was mainly characterized by the contribution of the.
Medica Spa announced Monday that it has invested, taking over a 20 percent stake, in the share capital of the newly established Medico MedTech Co. Ltd. Medico MedTech is a trading company based in.
Medica Spa reported on Friday that it had closed the first half of the year with preliminary consolidated sales of approximately EUR33.6 million, a significant increase compared to the sales achieved.